Effect of interferon therapy on the incidence of hepatocellular carcinoma and mortality of patients with chronic hepatitis C.

被引：0
|
作者：
Kasahara, A
Hayashi, N
Sasaki, Y
Kakumu, S
Kiyosawa, K
Okita, K
机构：
[1] Osaka Univ, Suita, Osaka, Japan
[2] Aichi Med Coll, Nagoya, Aichi, Japan
[3] Shinshu Univ, Matsumoto, Nagano 390, Japan
[4] Yamaguchi Univ, Ube, Yamaguchi 755, Japan
来源：
HEPATOLOGY | 2000年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
807
引用
收藏
页码：361A / 361A
页数：1
相关论文
共 50 条
  • [1] Effect of interferon on incidence of hepatocellular carcinoma in patients with chronic hepatitis C
    Soga, K
    Shibasaki, K
    Aoyagi, Y
    HEPATO-GASTROENTEROLOGY, 2005, 52 (64) : 1154 - 1158
  • [2] Incidence of hepatocellular carcinoma after interferon therapy in patients with chronic hepatitis C
    Onodera, H
    Ukai, K
    Suzuki, M
    Minami, Y
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 181 (02): : 275 - 283
  • [3] Effect of interferon therapy on the incidence of hepatocellular carcinoma and mortality of patients with chronic hepatitis C: A retrospective cohort study of 738 patients
    Tanaka, H
    Tsukuma, H
    Kasahara, A
    Hayashi, N
    Yoshihara, H
    Masuzawa, M
    Kanda, T
    Kashiwagi, T
    Inoue, A
    Kato, M
    Oshima, A
    Kinoshita, Y
    Kamada, T
    INTERNATIONAL JOURNAL OF CANCER, 2000, 87 (05) : 741 - 749
  • [4] Interferon retreatment reduces or delays the incidence of hepatocellular carcinoma in patients with chronic hepatitis C.
    Hino, K
    Yamaguchi, Y
    Fujiwara, D
    Satoh, Y
    Kitase, A
    Korenaga, M
    Shingai, Y
    Konishi, T
    Yamashita, S
    Mori, K
    Kodama, T
    Okita, K
    HEPATOLOGY, 2001, 34 (04) : 329A - 329A
  • [5] Incidence of hepatocellular carcinoma in chronic hepatitis C after interferon therapy
    Hayashi, K
    Kumada, T
    Nakano, S
    Takeda, I
    Kiriyama, S
    Sone, Y
    Toyoda, H
    Shimizu, H
    Honda, T
    HEPATO-GASTROENTEROLOGY, 2002, 49 (44) : 508 - 512
  • [6] The effect of retreatment with interferon-α on the incidence of hepatocellular carcinoma in patients with chronic hepatitis C
    Toyoda, H
    Kumada, T
    Nakano, S
    Takeda, I
    Sugiyama, K
    Kiriyama, S
    Sone, Y
    Hisanaga, Y
    CANCER, 2000, 88 (01) : 58 - 65
  • [7] Interferon for decreasing the incidence of hepatocellular carcinoma in patients with chronic hepatitis C
    Hayashi, N
    Kasahara, A
    ONCOLOGY, 2002, 62 : 87 - 93
  • [8] Immunodulator Effects of Interferon Therapy on Incidence of Cirrhosis and Hepatocellular Carcinoma in Patients with Chronic Hepatitis C
    Kutala, Blaise
    Boyer, Nathalie
    Marchand, Corinne Castelnau
    Guigui, Nathalie Giuily
    Sitruk, Veronique
    Asselah, Tarik
    Marcellin, Patrick
    HEPATOLOGY, 2018, 68 : 407A - 408A
  • [9] Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C
    Imai, Y
    Kawata, S
    Tamura, S
    Yabuuchi, I
    Noda, S
    Inada, M
    Maeda, Y
    Shirai, Y
    Fukuzaki, T
    Kaji, I
    Ishikawa, H
    Matsuda, Y
    Nishikawa, M
    Seki, K
    Matsuzawa, Y
    ANNALS OF INTERNAL MEDICINE, 1998, 129 (02) : 94 - 99
  • [10] The incidence of hepatocellular carcinoma in patients with chronic hepatitis C after interferon treatment
    Miyajima, I
    Sata, M
    Kumashiro, R
    Uchimura, Y
    Ide, T
    Suzuki, H
    Tanikawa, K
    ONCOLOGY REPORTS, 1998, 5 (01) : 201 - 204
12345